Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease
When Bristol Myers Squibb bought the heart disease-focused biotech MyoKardia for $13 billion in cash in the fall of 2020, it was seen as an
When Bristol Myers Squibb bought the heart disease-focused biotech MyoKardia for $13 billion in cash in the fall of 2020, it was seen as an
The Johns Hopkins Bloomberg School of Public Health will host an expert briefing for the media to discuss trends in tobacco use, the implications of
Preparing cancer patients for difficult decisions is an oncologist’s job. They don’t always remember to do it, however.
Pittcon 2025 in Boston will connect industry experts to combat the synthetic psychedelic threat, enhancing testing protocols and public health initiatives.
Elderberry juice rich in anthocyanins boosts glucose regulation and fat metabolism, with significant effects on gut microbiota in overweight adults.
The advance of H5N1 bird flu reminds us that novel pathogens remain a stubborn threat. Although a full-blown pandemic doesn’t appear imminent, the virus’s ability
The acceleration of artificial intelligence is arriving just in time for the biopharmaceutical industry. The global demand for innovative, effective treatments is growing faster than ever as
Research reveals sex-specific free-carnitine deficiency in women with cognitive impairment, linking mitochondrial metabolism to Alzheimer’s disease progression.
UltraMarathonRT® RT-qPCR Kit offers unmatched data reliability and sensitivity for gene expression studies, streamlining workflows and preserving RNA integrity.
In mechanobiology, cells’ forces have been considered fundamental to their enhanced function, including fast migration.